Ulrike Baro is a German businesswoman, one of the three daughters of Horst Sartorius, who passed on a 50% stake in biopharmaceutical firm Sartorius AG (FWB: SRT) after his death in 1998.

The company has roots dating back to 1870 when her great-grandfather Florenz Sartorius founded the firm to make analytical balances to measure small mass in laboratories. Sartorius AG, which went public in 1990, today makes a wide range of pharmaceutical and laboratory equipment.

• Core Company: Sartorius AG (Pharmaceutical and laboratory equipment).
• Family Link: One of the three daughters of Horst Sartorius.
• Scale: Has around 13,528 employees and revenue of $3.66 billion (FY 2024).

Ulrike Baro's wealth is generational, derived from the family's substantial stake in Sartorius AG. Her structural position is tied to the long-term stewardship of the company, which grew from a small workshop making analytical balances into a global supplier of equipment crucial for life science research and biopharmaceutical manufacturing.

Today, the company is publicly listed and has a global presence, with around 13,528 employees and annual revenue exceeding $3.66 billion (FY 2024).

• Ownership: Inherited a share of the 50% stake passed down by her father in 1998.